Loading company…
TransMedics develops organ transplantation technologies, including its Organ Care System.
Founded in 1998 and based in Andover, US, TransMedics develops technologies for organ transplantation. Its Organ Care System (OCS™) supports lung, heart, and liver transplants using normothermic perfusion. The company reported USD 441.54 mn in revenue and USD 57.25 mn in EBITDA for 2024. Its latest funding was a USD 400.00 mn venture debt round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in